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Abstract
Mycobacterium tuberculosis infection presents across a spectrum in humans, from latent
infection to active tuberculosis. Among those with latent tuberculosis, it is now recognized
that there is also a spectrum of infection and this likely contributes to the variable risk of
reactivation tuberculosis. Here, functional imaging with 18F-fluorodeoxygluose positron
emission tomography and computed tomography (PET CT) of cynomolgus macaques with
latentM. tuberculosis infection was used to characterize the features of reactivation after
tumor necrosis factor (TNF) neutralization and determine which imaging characteristics
before TNF neutralization distinguish reactivation risk. PET CT was performed on latently
infected macaques (n = 26) before and during the course of TNF neutralization and a sepa-
rate set of latently infected controls (n = 25). Reactivation occurred in 50% of the latently
infected animals receiving TNF neutralizing antibody defined as development of at least
one new granuloma in adjacent or distant locations including extrapulmonary sites.
Increased lung inflammation measured by PET and the presence of extrapulmonary
involvement before TNF neutralization predicted reactivation with 92% sensitivity and speci-
ficity. To define the biologic features associated with risk of reactivation, we used these PET
CT parameters to identify latently infected animals at high risk for reactivation. High risk ani-
mals had higher cumulative lung bacterial burden and higher maximum lesional bacterial
burdens, and more T cells producing IL-2, IL-10 and IL-17 in lung granulomas as compared
to low risk macaques. In total, these data support that risk of reactivation is associated with
lung inflammation and higher bacterial burden in macaques with latent Mtb infection.
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Author Summary
Asymptomatic infection withMycobacterium tuberculosis, often called latent tuberculosis,
affects more than 2 billion people. Reactivation of latent infection to active TB occurs in
only a minority of those infected, yet can lead to deadly disease and transmission. Here we
show, using a non-human primate model, that imaging using PET/CT can identify certain
features that are associated with a higher risk of reactivation. These factors include overall
lung inflammation, individual granulomas in the lung with higher bacterial burden, and a
site of infection outside the lungs. Using these parameters may allow discovery of periph-
eral biomarkers regarding risk of reactivation from latent TB. Such biomarkers could iden-
tify those people who would benefit most from treatment of latent TB to prevent
reactivation.
Introduction
The vast majority of people infected withMycobacterium tuberculosis (Mtb) develop asymp-
tomatic, latent infection (LTBI). It is increasingly recognized that there is a spectrum of LTBI
in humans, and this spectrum may correlate with the risk of reactivation [1]. Although reacti-
vation risk is estimated at 10% per lifetime in HIV-negative LTBI humans, this is a population
level estimate. Instead, it seems more likely that a small percentage of those with LTBI are at
higher risk of reactivation. However, it has been challenging to identify the small fraction of
the more than 2 billion latently infected humans who are at greatest risk of reactivation, so that
therapy can be targeted to that population.
As in humans, LTBI in macaques is a stable, asymptomatic infection without clinical signs
[2]. Reactivation of LTBI can be triggered in macaques by immune suppression due to SIV
infection, TNF neutralization and CD4 depletion [3–6], but variable rates of reactivation are
observed, similar to humans. We hypothesize that the spectrum of LTBI is associated with sus-
ceptibility to reactivation [1, 2]. Here we develop criteria based on 18F-fluorodeoxyglucose
(FDG) positron emission tomography coupled with computed tomography (PET CT) imaging
of macaques with LTBI to predict reactivation risk due to TNF neutralization. These criteria
were then applied to latently infected macaques (without TNF neutralization) to identify bio-
logic features that correlate with higher risk of reactivation. Macaques at high reactivation risk
had greater cumulative lung bacterial burden, higher bacterial burden within an individual
granuloma, more Mtb-infected mediastinal lymph nodes, and more T cells producing IL-2,
IL-10 and IL-17 in lung granulomas compared to low risk macaques. Our results support the
model of a spectrum of latency, suggesting that the extent and quality of bacterial control as
well as lung inflammation in latency determines risk of reactivation after TNF neutralization.
Results
PET CT patterns of reactivation during TNF neutralization
We have previously published criteria for determining whether cynomolgus macaques withM.
tuberculosis infection are “active” or “latent” by 6 months post-infection, based on clinical and
microbiologic tests, as in humans [2, 7]. These clinical classifications were confirmed at nec-
ropsy, where those classified as active TB had significantly more pathology and bacterial bur-
den than those classified as latent [2]. In this study, our aim was to determine whether we
could identify latently infected macaques that would be more susceptible to reactivation. To do
this, we employed serial FDG PET CT imaging, prior to and during neutralization of TNF,
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which we have shown previously can induce reactivation in macaques [5]. A cohort of cyno-
molgus macaques with LTBI (n = 26) was PET CT imaged at least 6 months post-infection,
immediately prior to being randomly assigned to receive either TNF neutralizing antibody for
5–8 weeks or no treatment. Each macaque was evaluated for reactivation which was strictly
defined here as dissemination, determined by the appearance of at least one new granuloma in
lungs or extrapulmonary sites by PET CT during anti-TNF antibody treatment (Fig 1). Of 26
animals with TNF neutralization, 50% (n = 13) developed new lesions. At necropsy, macaques
that developed new granulomas during TNF neutralization had greater disease pathology and
higher total bacterial burden in lungs (Fig 2A and 2B) as well as within individual granulomas
and lymph nodes (S1 Fig). Animals that developed reactivation had a significantly smaller pro-
portion of sterile (or greater proportion with Mtb growth) among granulomas and mediastinal
lymph nodes compared to animals that did not reactivate (Fig 2C and 2D). Thus, these data
support the use of dissemination, the formation of new lesions in lungs or extrapulmonary
sites, as a primary metric of reactivation.
While we defined reactivation in terms of bacterial dissemination, we postulated that we
might also see evidence of loss of bacterial control among pre-existing lesions from the animals
that reactivated. We examined lesion specific changes in metabolic activity (FDG avidity of
each granuloma by PET, reported as standard uptake value, SUV) and/or size (by CT) during
TNF neutralization. Granulomas were classified as “stable” if they remained similar in SUV
(change< 5 units) or size (change< 1mm) or “dynamic” if they increased in SUV ( 5 units)
or size (1mm) (S2 Fig). At least 1 dynamic lesion was observed during TNF neutralization in
69% (9 of 13) of reactivated monkeys compared to only 31% (4 of 13) among non-reactivated
animals. Dynamic lesions were less likely to be sterile and had significantly higher bacterial
Fig 1. PET CT features of reactivation tuberculosis during TNF neutralization. Axial views of the lung are shown from two representative
latently infected macaques with granulomas seen before (left panels, top and bottom) and during the course of TNF antibody treatment (middle and
right panels, top and bottom). Pre-existing lesions (green arrows) within the same lung lobe can increase in size and FDG avidity or remain the
same during the TNF neutralization. New lesions (red arrows) can arise in the lungs in an already involved lobe (top row) and/or in a new lobe or
extrapulmonary sites such as the liver (red arrows, bottom row).
doi:10.1371/journal.ppat.1005739.g001
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Fig 2. Disease pathology, bacterial burden and bacterial killing after TNF neutralization among reactivated and non-
reactivated animals. (A) Macaques with radiographically defined reactivation have greater gross pathology at necropsy
compared to animals that did not reactivate. Each symbol represents an animal. Statistics: Mann-Whitney (B) Thoracic bacterial
burden (the sum ofMtb growth from all lung granulomas, other lung pathologies and all mediastinal lymph nodes, [MLN]) is
higher in reactivated animals than in non-reactivated animals after TNF neutralization. Each symbol represents an animal.
Statistics: Mann-Whitney (C) The number of granulomas among animals that developed reactivation (N = 13 macaques, 114
granulomas) are shown with the proportion of sterile granulomas reported in light green compared to animals that did not
reactivate (N = 12 macaques, 100 granulomas). The p-value shown compares the proportion of sterile granulomas between
groups of animals (Fisher’s Exact analysis). Up to 10 granulomas (randomized) are represented per animal to reduce bias. (D)
Animals with reactivation had a smaller proportion of sterile MLNs compared to animals that did not reactivate. Proportions of
sterile MLN are shown in the context of the total number of MLN in each group (reactivated group: N = 13 macaques, 85 MLNs
vs non-reactivated group N = 13 macaques, 87 MLNs). The p-value shown compares the proportion of sterile granulomas
between groups of animals (Fisher’s Exact analysis). Up tp 7 lymph nodes (randomized) are represented per animal to limit
bias. (E) Dynamic granulomas (N = 42) had greater CFU per granuloma than stable (N = 132) and new (N = 23) granulomas
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burdens (measured as colony forming units, CFU) compared to stable lesions (Fig 2E) among
all TNF-neutralized animals. The frequency of sterile lesions among new, stable and dynamic
lesions was statistically different (Fig 2E) with the lower proportion of sterile lesions among the
dynamic and newly developed granulomas. The total number of granulomas per monkey
among reactivated (median = 12, IQR25 = 8,IQR75 = 24.5) and non-reactivated (median = 8,
IQR25 = 4.5, IQR75 = 19.5) animals was similar (Mann-Whitney, p = 0.3). These data suggest
that the increased bacterial burden observed in reactivation is not solely driven by the number
of new lung granulomas but likely a combination of granuloma types and MLN burden.
We also compared the ratio of live Mtb CFU to chromosomal equivalents (CEQ) (the
cumulative burden of live and dead Mtb) to estimate bacterial killing [8] in dynamic and stable
lesions. Dynamic granulomas had higher CFU/CEQ ratios (i.e., less bacterial killing) than sta-
ble granulomas among all animals undergoing TNF neutralization (Fig 2F). Granulomas from
reactivated animals had higher CFU/CEQ ratios compared to non-reactivated animals and
LTBI controls (that did not receive TNF antibody) (S3 Fig). Importantly, however, many
lesions in reactivated animals did not increase in metabolic activity or size or display reduced
killing after TNF neutralization. This supports our previous data that demonstrates marked
heterogeneity of lesions within an individual animal [8–11].
PET CT patterns are associated with risk of reactivation of latent
infection
We next sought to identify PET CT characteristics of macaques prior to TNF neutralization
that are predictive of reactivation risk. The number of lung granulomas observed before TNF
neutralization was similar between animals that reactivated and those that did not (Fig 3A).
We have previously shown that overall lung inflammation (total lung FDG avidity) detected by
PET is loosely associated with lung bacterial burden in macaques with active TB, and decreased
dramatically with anti-TB drug treatment [10, 12]. In this study, total lung FDG avidity imme-
diately prior to anti-TNF treatment was significantly higher in animals that would later reacti-
vate (Fig 3B) compared to those that did not. We then sought to define the distinguishing
characteristics of individual lung granulomas prior to anti-TNF treatment that correlated with
reactivation risk. Animals that would develop reactivation had a higher proportion of FDG
avid (defined as SUV 5) granulomas (67.2%) compared to non-reactivator animals (30.8%)
(Fisher’s Exact, p<0.0001) before TNF neutralization. Comparing the single most FDG avid or
the largest size granuloma in each animal prior to anti-TNF treatment showed that those that
would develop reactivation had a granuloma that was larger or had higher FDG avidity (Fig 3C
and 3D). Although dynamic lesions had higher FDG avidity (median SUV 8.8, IQR 25–75: 5.0,
13.9) compared to stable lesions (median SUV 4.5, IQR25-75: 2.9, 7.5, Mann-Whitney,
p<0.0001) before TNF neutralization, we were unable to predict which lesions would become
dynamic as only 23.7% of the lesions with greatest SUV and 31.6% of lesions of maximum size
were dynamic lesions after TNF neutralization.
FDG avid mediastinal lymph nodes (MLN) seen on PET CT are usually associated with
Mtb involvement. Previous data from our lab and from human studies suggest that infected
MLN are a potential source of reactivation [5, 6, 13]. The cumulative FDG avidity of hot MLNs
was significantly higher among animals that would later reactivate (reactivators cumulative
SUV median = 9.6, IQR25-75: 5.8, 31.5 vs. non-reactivators cumulative SUV median = 5.5,
after TNF neutralization. Percent sterile granulomas is noted for each group. Statistics: Kruskal-Wallis with Dunn’s multiple
comparisons. (F) Dynamic lesions had less bacterial killing compared to stable lesions, as assessed by CFU/CEQ ratio.
Statistics: MannWhitney. The numbers indicated above each figure represents the p-value for the given statistical method.
doi:10.1371/journal.ppat.1005739.g002
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IQR25-75: 0, 13.9, Mann-Whitney, p = 0.04). Lastly, the number of extrapulmonary sites of
infection before TNF neutralization was significantly higher in animals that would later
develop reactivation compared to those that would not (Fig 3E).
To assess which PET CT variables could distinguish reactivators from non-reactivators
before TNF neutralization, we ran several different simple logistic regression models (and a
contingency analysis) to narrow down the best predictors using the following variables: total
lung FDG activity, number of “hot” lymph nodes, total number of lymph nodes, total SUV of
lymph nodes, number of lesions, and the presence of extrapulmonary lesions. We chose total
lung FDG activity and the presence of extrapulmonary lesions as best predictors based on
goodness of fit. We then used recursive partitioning, splitting the data into a decision tree to
define an optimal cut-off (947.2 SUV) for total lung FDG activity. Combining the presence of
extrapulmonary involvement and total lung FDG avidity resulted in favorable receiver operator
Fig 3. PET CT characteristics that distinguish reactivated and non-reactivated animals prior to TNF neutralization. (A) Similar
numbers of lung granulomas are observed by PET CT in animals that reactivated and those that did not. (B) Total lung FDG avidity is higher
prior to TNF neutralization in macaques that reactivated compared to those that did not. Macaques with an extrapulmonary lesion site (before
TNF neutralization) are depicted are in pink. (C, D) The maximum FDG avidity (SUV) and size of any granuloma within a single monkey
before TNF neutralization was greater among reactivator compared to non-reactivator animals. Each symbol represents an animal. (E) The
number of extrapulmonary (EP) lesion sites before TNF neutralization was greater in animals that reactivated compared to those that did not.
(F) A receiver operator curve (ROC) was calculated (AUC = 0.94) based on the presence of EP lesions and total lung FDG avidity (cut-off of
947.2 SUV) showing high sensitivity (92%) and specificity (92%). Panels A-D: each symbol represents a macaque. Statistics for A-E: Mann-
Whitney. The numbers in each figure represents the p-value each analysis.
doi:10.1371/journal.ppat.1005739.g003
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curve results (area under the curve = 0.94) and a high sensitivity (92.3%) and specificity
(92.3%) (Fig 3F).
Bacterial- and immunologic-associated risks of reactivation
It was not feasible to administer TNF neutralizing antibody to another large set of latently
infected macaques to validate our predictions or identify biologic features associated with reac-
tivation risk. Therefore we leveraged a set of latent control macaques (N = 25) that were nec-
ropsied concurrently with the TNF neutralized group, categorizing them being as at high or
low risk for reactivation based on our PET CT defined parameters (i.e., total lung FDG avidity
and extrapulmonary involvement) using the scan prior to necropsy. Animals who had evidence
of extrapulmonary involvement on scan or a total lung FDG avidity of greater than or equal to
947.2 were classified as high risk. We then analyzed lesions from these animals to investigate
the bacterial and immunological factors associated with risk of reactivation. While the median
CFU per granuloma was the same between high and low risk animals (S4 Fig), a wide range of
CFU per granuloma was observed within each individual monkey (S5 Fig). Because low risk
animals appeared to have a lower peak bacterial burden compared to high risk, we then com-
pared the maximum CFU per single granuloma within an in individual monkey to limit the
bias. Interestingly, the maximum CFU per single granuloma within an animal was also higher
among high risk compared to low risk animals (Fig 4A, S6 Fig). The total lung CFU (cumula-
tive CFU of all lesions in the lung) was also greater among high-risk LTBI animals (Fig 4B, S6B
Fig). High-risk LTBI animals also had a trend toward greater CFU per MLN (Fig 4C), which
was surprising given the large range of CFU per MLN on an individual animal level (S7 Fig).
High risk animals also had a smaller proportion of sterile MLN (i.e., greater proportion of
MLN with Mtb growth) compared to low risk animals (Fig 4D). Together these data indicate
that individual lesional characteristics (i.e., high bacterial burden in one granuloma or lymph
node) are associated with high risk of reactivation.
We then examined Mtb-specific T cell cytokine production within individual lung granulo-
mas and blood of high- (n = 10) and low-risk (n = 10) LTBI control animals (without TNF neu-
tralization). Granulomas from high-risk animals had higher frequencies of IL-17, IL-10 or IL-2
producing CD3+ T cells as compared to granulomas from low risk animals (Fig 5, S9 Fig).
While most T cells from granulomas were single cytokine producers, as we previously
described [9], we found that high-risk animals had a higher percentage of granuloma T cells
producing more than one cytokine. There were no differences in frequencies of Mtb specific
cytokine production by CD4+ and CD8+ T cells or by memory subsets in peripheral blood (S9,
S10 and S11 Figs). These data suggest that granulomas from high-risk LTBI animals are more
immune stimulated, possibly due to higher bacterial activity, although the specific factors driv-
ing this are unknown.
Discussion
In this study, we strictly defined reactivation following TNF neutralization based on dissemina-
tion (formation of at least one new granuloma) and validated that definition at necropsy,
where reactivated macaques had higher bacterial burden than those that did not reactivate.
Together the data in this study support the hypothesis that the spectrum of latency has implica-
tions for risk of reactivation. Here we provide evidence that lung inflammation and/or evidence
of extrapulmonary involvement detected by PET CT is associated with reactivation risk follow-
ing TNF neutralization in macaques. In addition, reactivation risk is correlated with at least
one granuloma of larger size or higher inflammation (measured by PET).
PET CT Identifies Reactivation Risk from Latent Tuberculosis
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This unique set of data provided the opportunity to investigate individual granulomas in
macaques predicted to be at high or low risk of reactivation. Using the parameters we devel-
oped based on PET CT characteristics of LTBI macaques that did or did not reactivate follow-
ing TNF neutralization, we predicted the risk of reactivation of 25 latent control macaques.
Neutralizing TNF would change the bacterial and immunologic features in these animals,
which would prevent investigation of these factors in risk of reactivation. Therefore, instead of
testing our prediction by treating the animals with anti-TNF treatment, we compared several
factors in our predicted high or low risk animals without further intervention. Animals pre-
dicted at high risk had higher total lung and lymph node bacterial burden. In addition, an indi-
vidual granuloma in high risk animals had a high bacterial burden, suggesting that a single
poorly contained granuloma can contribute to reactivation. T cell cytokine production in gran-
ulomas was higher in high risk compared to low risk macaques in the absence of TNF neutrali-
zation. This could be due to more bacterial replication and antigen production in high risk
animals. Alternatively, the combination of cytokines in certain granulomas from high risk
Fig 4. Parameters of reactivation risk in latently infected control macaques (without TNF neutralization). Animals were stratified
for high or low risk of reactivation based on cut-offs determined by recursive partitioning (high = 947.2 Total FDG Activity or the
presence of extrapulmonary lesions). (A) The maximumCFU per granuloma for an individual animal is greater in high-risk (N = 10)
compared to low risk (N = 12) animals. (B) High risk LTBI control animals had higher total lung bacterial burden compared to low risk
LTBI animals. (C) A trend toward higher CFU per individual MLN was observed in high-risk compared to low-risk LTBI animals. Up to 7
MLN are represented per animal to limit bias. (D) The proportion of sterile MLN observed among low and high risk LTBI controls is
shown in the context of the total number of MLN per group. A greater proportion of sterile MLN was observed in low risk LTBI controls
compared to high risk animals. The p-value shown compares the proportion of sterile MLN between groups of animals (Fisher’s Exact
analysis). Statistics for A-C: Mann-Whitney.
doi:10.1371/journal.ppat.1005739.g004
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animals may provide a less stable host immune environment. Further studies of immune
responses in granulomas from low or high risk animals is necessary to differentiate cause and
effect of cytokine responses in predisposing animals to reactivation. The data from this study
suggests that only one or a few granulomas need to fail in bacterial containment to lead to dis-
semination and reactivation.
Not all granulomas were equally affected by TNF neutralization, suggesting that reactivation
and dissemination can occur from as few as one unstable granuloma. For example, TNF neu-
tralization led to dynamic granulomas (increasing in size or FDG avidity), but this was
restricted to a subset of granulomas in reactivating monkeys. This is consistent with the inde-
pendent and dynamic nature of lung granulomas in this model [8–11]. However, given the lack
of current technology for tracking individual bacilli, it is not possible to confirm that dynamic
lesions, or those with higher bacterial burden, are the source of dissemination. A limitation of
this study is that we are unable at this time to identify direct causes of increased bacterial bur-
den or instability of lesions, which are both associated with reactivation.
The ability of mediastinal lymph nodes (MLN) to control infection during clinical latency
also appears to contribute to risk of reactivation. In LTBI, a Ghon complex refers to the combi-
nation of a lung granuloma and an involved lymph node, suggesting lymph node involvement
is common in humans. Studies from the pre-antibiotic era also demonstrate substantial lymph
node involvement in humans soon after infection [14]. Similarly, mediastinal lymph nodes
have been detected by PET CT in humans with Mtb infection [15–18]. Thus, the role of lymph
nodes in susceptibility to reactivation is likely important [19] and should be targeted in the
development of drugs to treat latent infection. We previously published an association between
extent of CD4 depletion in MLN and reactivation in latently infected macaques treated with
CD4-depleting antibody [6]. In this current study, the latent controls predicted to be at high
Fig 5. Frequencies ofMycobacterium tuberculosis (Mtb) specific T cells producing cytokines from individual granulomas of LTBI controls at
high (N = 9) or low risk (N = 7) of reactivation. T cells from granulomas were stimulated with ESAT-6 and CFP-10 peptides. The frequency of T cells
producing only IL-10 (A), only IL-17 (B) or only IL-2 (C) was greater in granulomas from high-risk compared to low risk LTBI animals. No differences were
observed in IFN- γ (D) or TNF production (E). Each symbol represents a granuloma. Statistics: Mann-Whitney.
doi:10.1371/journal.ppat.1005739.g005
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risk of reactivation a greater proportion of MLNs with Mtb growth compared to those that
were at low risk. However, in a previous study, macaques vaccinated with BCG plus the protein
fusion H56 vaccine were protected against TNF-neutralization induced reactivation [20].
Examination of our data from that study shows that protection against reactivation was associ-
ated with significantly fewer Mtb positive MLN (S12 Fig). Thus, it is likely that the MLN play
an important role in reactivation risk. Even less is known about the presence of extrapulmon-
ary sites of infection during LTBI. While it occurs in humans [21, 22], the actual prevalence
has not been well described. We speculate that the events that result in extrapulmonary infec-
tion being established are due to poor initial control and early dissemination, which is then
associated with reactivation risk.
In summary, we have provided evidence that the spectrum of clinically defined LTBI, specif-
ically that associated with inflammation detected by PET CT and the presence of extrapulmon-
ary disease, is associated with reactivation risk. It is likely that this occurs in humans with LTBI
and similar lung lesions have been described in LTBI humans by PET CT [16, 23–25]. Impor-
tantly, this is the first assay that can functionally distinguish those at high and low risk for reac-
tivation induced by TNF neutralization. We recognize that using PET CT to stratify
reactivation risk is not feasible in most human settings. However, the use of PET CT in this
well characterized animal model provides an opportunity to identify potential biomarkers in
blood, including transcriptional signatures, which may correlate with reactivation risk. Priori-
tizing treatment to those patients at increased risk of reactivation (especially those with HIV
infection) is a more efficient strategy in our current efforts to eradicate TB, as most programs
are unable to provide treatment to all LTBI patients.
Materials and Methods
Animals
Adult ( 4 years of age) cynomolgus macaques (Macacca fasicularis) (Valley Biosystems, West
Sacramento, CA) were screened with standard tests for co-morbidities prior to infection with
Mtb as previously published[26]. Animals were maintained in a Biosafety Level 3 facility for
primates afterM. tuberculosis infection.
Cynomolgus macaques were infected with low dose (~25 CFU) ofM. tuberculosis (Erdman
strain) via bronchoscopic instillation into a lower lung lobe and subsequent serial clinical,
microbiologic and immunologic parameters were followed until outcome was determined as
previously described [2, 7]. Once animals were classified as latent, a subset was randomized to
receive TNF neutralizing agent Adalimumb (Humira, Abbott Labs, Abbott Park, IL) at 4 mg/
kg/dose subcutaneously every 7–10 days [5]. In general, PET-CT scans were performed at base-
line before TNF neutralization and every 2 weeks after treatment until 5–8 weeks. A pre-nec-
ropsy scan was performed on all animals to facilitate harvesting scan-identified lesions. Serial
analysis of these lesions before and during treatment was performed (see below). At necropsy,
animals were maximally bled and gross pathology was assessed using our previously published
quantitative scoring system in which a number is given for the size, number and pattern of
granulomas in each lung lobe, mediastinal lymph node and extrapulmonary sites (e.g., liver,
spleen). Harvested lung granulomas are characterized, measured and processed into single cell
suspension for bacterial burden and flow cytometry as previously reported [2, 9].
Ethics statement
All animal protocols and procedures were approved by the University of Pittsburgh’s Institu-
tional Animal Care and Use Committee (protocol assurance number A3187-01.) Our specific
protocol approval numbers for this project are 0808244, 0906877, 1011342,1105870 and
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11080037. The IACUC adheres to national guidelines established in the Animal Welfare Act (7
U.S.C. Sections 2131–2159) and the Guide for the Care and Use of Laboratory Animals (8th
Edition) as mandated by the U.S. Public Health Service Policy.
PET CT imaging and analysis
At predetermined time points, animals were sedated, intubated and imaged by 2-deoxy-
2-18F-D-deoxyglucose (FDG) PET (microPET Focus 220 preclinical PET scanner, Siemens
Molecular Solutions, Knoxville, TN) and CT (Neurologica Corp, Danvers, MA) imaging within
our biosafety level 3 facility as previously described [10, 12, 27]. Lesions were identified by two
analysts (M.T.C. and P.M.) and size was measured by CT. FDG avidity was measured by draw-
ing a region of interest (ROI) in the axial view and SUVs (standard uptake volume,
SUV = counts/(injected activity/body weight), normalized to muscle to reduce variability
between scans, were calculated using OsiriX (Pixmeo, Geneva, Switzerland) as previously pub-
lished [27].
The total lung FDG avidity was analyzed and calculated using Osirix viewer, an open-source
PACS workstation and DICOM viewer. The whole lung was segmented on CT by using the
Growing region algorithm on the OsiriX viewer to create a ROI of normal lung (Hounsfield
units between -1024 and -200). The closing tool was used to include individual nodules and
other pulmonary disease. The ROI was transferred to the co-registered PET scan and manually
edited to ensure all pulmonary disease was included. All extrapulmonary structures and dis-
ease, including mediastinal lymph nodes, were excluded. Voxels outside the ROI were set to
zero and voxels within the ROI with an SUV higher than normal lung (SUV 2.3) were iso-
lated. These ROIs (capturing all SUV 2.3 within the lung) were exported into a spreadsheet
using the OsiriX “Export ROI” plugin. Finally, the sum from the pixels of each slice (from the
exported ROI) was calculated to represent the measurement of “Total Lung FDG Avidity”.
Granuloma specific changes observed before and during TNF neutralization were per-
formed. “Stable” lesions were defined as lesions that maintained the same size and FDG avidity
before and after TNF neutralization whereas “dynamic” lesions were those that that increased
in size by at least 1mm or FDG avidity by at least 5 SUV. “New” lesions were not present base-
line but appeared during the course of TNF neutralization.
Isolation and quantification ofM. tuberculosis genomes from tissue
samples
Following necropsy, tissue sample homogenates were stored in PBS at -80°C. At processing,M.
tuberculosis genomes were extracted with phenol-chloroform as previously described [8]. In
brief, blinded samples were re-suspended in 1 mL Tris-EDTA buffer, pH 8.0, with 300 μl of
70°C UltraPure phenol:chloroform:isoamyl alcohol (25:24:1) (Invitrogen) and 250 μl of 0.1
mm zirconia-silica beads (BioSpec Products, Inc.). Tubes were mixed by inversion, incubated
for 10 min, and twice vortexed for 4 min with a 1 min break at highest speed using a 24-tube
vortex adaptor (MO BIO Laboratories, Inc.). Following a 10 min centrifugation at 14,000 RPM
at 4°C, the aqueous layer of each sample was extracted and placed in a fresh tube with 50 μl of
5M sodium chloride. The phenol:chloroform:isoamyl alcohol extraction was repeated with
250 μl and a 30 min incubation at room temperature. After the incubation, samples were cen-
trifuged once more at 14,000 RPM for 30 min at 4°C to separate off the aqueous phase. One
volume of isopropanol and 1/10 volume of 3M sodium acetate (pH 5.2) was then added to each
extraction to precipitate genomic DNA with an overnight incubation at -20°C. Each DNA pel-
let was washed with 70% ethanol and centrifuged for 30 min as before. Each pellet was then left
to air-dry to remove excess ethanol and subsequently re-suspended in sterile nuclease free
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water (Ambion). DNA purity and concentration was measured using the Spectramax 190 spec-
trophotometer (Molecular Devices).
Quantification of chromosomal equivalents (CEQ) ofM. tuberculosis was performed using
real-time PCR of a single copy gene, Mtb sigF, with a previously described primer-probe com-
bination [8]. The primer and probes for this target were purchased together in a pre-mixed
PrimeTime qPCR assay (Integrated DNA Technologies). The sequences are as follows, 5’3’:
probe–FAM-TCG GAC TTC GTC TCC TTC-Iowa Black, sigF Fwd–GCG GGT CGG GCT
GGT CAA C, and sigF Rvs–CCT CGC CCA TGA TGG TAG GAA C. Real-time PCR was pre-
formed in duplicate on the iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad Labora-
tories, Inc.) and the 384well-capable 7900HT Fast Real Time PCR System (Applied
Biosystems) with TaqMan Universal Master Mix II (Life Technologies). Precise determination
of CEQ was derived from a standard curve of serially dilutedM. tuberculosis genomic DNA
prepared from liquid culture for each qPCR run. Real time PCR efficiency for each run was
maintained between 90% and 110%.
While the quantification of both live Mtb and chromosomal equivalents are estimates, the
ratios reflect a relative estimate of bacterial killing as published [8]. Accuracy of these estimates
both in the detection of live bacteria and chromosomal equivalents may be limited by potential
clumping of the bacteria resulting in underestimates of CFUs and minor variations in PCR
amplification based on sample-specific differences in protein contamination or PCR inhibitors
from blood.
Flow cytometric analysis
Intracellular cytokine analyses were performed on individual granulomas harvested at nec-
ropsy and on PBMC at predetermine time points (6 months post infection). As previously
described [9] single cell suspension of individual granulomas or PBMC were stimulated ex vivo
with peptide pools of Mtb specific antigens ESAT-6 and CFP-10 (10 μg/ml of every peptide) or
controls in the presence of Brefeldin A (Golgiplug: BD biosciences) for 3.5 hours (for granulo-
mas) or 6 hours (for PBMCs) at 37°C with 5% CO2. For PBMC, Brefeldin A was added after 1
hour stimulation with Mtb antigens or controls. Positive control included stimulation with
phorbol dibutyrate (PDBu) and ionomycin and negative controls included a media only con-
trol and an isotype controls (only for intracellular cytokine markers) for all PBMC samples and
for granulomas whenever additional cells were available. For flow cytometry, cells from granu-
lomas were initially stained for viability marker (Invitrogen) followed by cell surface marker
CD3 (clone SP34-2; BD Pharmingen) for T cells. Cell surface markers for PBMC T cells
included CD4 (clone L200, BD Horizon) and CD8 (clone SK1: BD biosciences) and markers
for T cell memory subsets included CD45RA (clone 5H9, BD biosciences) and CD27 (clone
O323, eBioscience). Intracellular cytokine staining panel for both granulomas and PBMC
included Th1 pro-inflammatory cytokines: IFN-γ (clone B27), IL-2 (clone: MQ1-17H12), TNF
(clone: MAB11); Th17 cytokine: IL-17 (clone eBio64CAP17) and regulatory cytokine: IL-10
(clone JES3-9D7) as previously described [9]. Data acquisition was performed using an LSR II
(BD) and analyzed using FlowJo Software v.9.7 (Treestar Inc, Ashland, OR). For all PBMC T
cells, the non-specific T cell response from the negative control (media) was subtracted from
the Mtb specific antigen stimulated responses. MIATA guidelines were followed for sample
collection and staining procedure for PBMC samples. The gating strategies used for the evalua-
tion of granulomas and PBMC are described in S8 and S9 Figs. Intracellular cytokine data from
granulomas in latent control animals (Fig 5) was previously published [9] but not analyzed
based on risk of reactivation. PBMC T cell cytokine data (S10 and S11 Figs) from a subset of
the animals was used for computational modeling and has been published [28].
PET CT Identifies Reactivation Risk from Latent Tuberculosis
PLOS Pathogens | DOI:10.1371/journal.ppat.1005739 July 5, 2016 12 / 17
Bacterial burden determinations
Single cell suspension of each harvested site (i.e., lung granulomas, complex pathologies,
grossly normal lung, MLN, liver, spleen) was plated on 7H11 plates (minimum detection level
ofM. tuberculosis burden was estimated at<10 Colony Forming Units per granuloma) as pre-
viously described [2, 8]. Specific bacterial burden of each site (granuloma, complex pathologies,
or MLN) was calculated as the product of the bacterial burden on a per gram basis and the
total mass of the tissue site.
Total thoracic burden was calculated as the sum of allM. tuberculosis growth from the lung
(includes all individual granulomas and more complex pathologies such as consolidations, TB
pneumonia, coalescing granulomas and clusters) and mediastinal lymph nodes. Total lung bur-
den was calculated as the sum of allM. tuberculosis growth from lung lesions without mediasti-
nal lymph nodes. The bacterial burden data were then transformed by adding 1 and reported
as CFU.
Statistical analysis
Normal distribution of the data was assessed for each continuous variable using the D’Agos-
tino-Pearson Omnibus Test. For statistical comparison, pair-wise analysis of continuous data
was performed by Student's T test for normally distributed data and Mann-Whitney test for
nonparametric data. For analyses in which more than two groups were compared, Kruskall-
Wallis test was performed with Dunn’s multiple comparisons as a post-hoc test of non-nor-
mally distributed data. Pair-wise analysis for matched data was performed using the Wilcoxon
rank-sum test. P-values below 0.10 were reported specifically in figures and text.
To assess which PET CT variables could distinguish reactivators from non-reactivators
before TNF neutralization, we ran several different simple logistic regression models (and a
contingency analysis) to narrow down the best predictors using the following variables: total
lung FDG activity, number of “hot” lymph nodes, total number of lymph nodes, total SUV of
lymph nodes, number of lesions, and the presence of extrapulmonary lesions. We chose total
lung FDG activity and the presence of extrapulmonary lesions as best predictors based on
goodness of fit and then used recursive partitioning (a decision tree) to evaluate a cut-off for
total lung FDG activity. A receiver operating characteristic (ROC) curve was plotted in order to
graphically represent the sensitivity and specificity of the combination of these two predictors.
Statistical analysis was performed using Prism 6.0 (Graphpad Software, Inc). The ROC curve
was plotted in JMP Pro 10.2 (SAS Institute Inc.).
Given the variability in the number of granulomas per animals, methods were developed to
minimize the potential for bias among animals that had a greater number of lesions (i.e., granu-
lomas and MLN) for analysis. We derived a number of representative samples per monkey by
first calculating the median number of samples (for which we had bacterial burden) per mon-
key per group so that one monkey could not contribute more than the median number of sam-
ples per monkey.
Supporting Information
S1 Fig. (A) Granuloma colony forming units (CFU) are higher in reactivated (N = 13
macaques, 114 granulomas) compared to non-reactivated (N = 12 macaques, 100 granulomas)
animals. Each symbol represents an individual granuloma. The number of sterile granulomas
is noted for each group. 10 granulomas (randomized) are represented per animal. (B) CFU of
individual MLN are greater in reactivated (N = 13 macaques, 85 MLNs) compared to non-reac-
tivated (N = 13 macaques, 87 MLNs) animals. Each symbol represents an individual MLN and
7 lymph nodes (randomized) are represented per animal. Percent sterile MLN is noted for each
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group. The p-value indicated above reflects a comparison of the median CFU per granuloma
or MLN between groups (Mann-Whitney).
(TIF)
S2 Fig. Radiographically dynamic and stable lesions of latently infected macaques during
neutralization. PET CT images from a macaque before and during TNF neutralization show
examples of “stable” lung granulomas (top row, yellow arrows) defined has having no substan-
tial change in FDG avidity or size. In contrast, in a different lung location in this same animal,
dynamic lung lesions are seen (bottom row, yellow arrows) and are defined as granulomas that
increase substantially in size (1mm) and/or FDG avidity ( 5 units) during the course of
TNF neutralization.
(TIF)
S3 Fig. Bacterial killing in granulomas is reduced in reactivated macaques compared to
those that did not reactivate following TNF neutralization or LTBI controls. The ratio of
liveM. tuberculosis colony forming units (CFU) to chromosomal equivalents (genomic quanti-
ties of both live and deadM. tuberculosis) is used to estimate bacterial growth and killing. Less
killing (or higher CFU/CEQ ratio) is observed among granulomas from reactivated animals
compared to non-reactivated animals given TNF antibody as well as from latently infected con-
trol animals (LTBI) not given anti-TNF antibody. P-values shown were performed by Krus-
kall-Wallis with post-hoc Dunn’s multiple comparison. Open symbols represent dynamic
lesions, closed symbols represent stable lesions, and pink shaded circles represent new lesions.
(TIF)
S4 Fig. Bacterial burden per granuloma is higher in high risk compared to low risk
macaques without anti-TNF treatment. Animals were stratified for high (N = 10) and low
(N = 12) risk of reactivation. (A) Bacterial burden per granulomas (CFU/gran) was greater in
high risk compared to low risk LTBI animals although the medians were the same (median = 1).
10 granulomas (randomized) are represented per animal. The proportion of sterile granulomas
is noted for each group. The p-value shown was performed by Mann-Whitney. (B) The pro-
portion of sterile granulomas is shown relative to the total number of granulomas from all
monkeys in each risk group. A trend toward a lower percentage of sterile granulomas was
observed in high risk animals compared to low risk. The p-value reflects the proportion of ster-
ile granulomas in each risk group (Fisher’s Exact).
(TIF)
S5 Fig. Range of bacterial burden per granuloma (CFU/gran) for each high (N = 10) and
low (N = 12) risk latent control macaque. Each symbol represents an individual granuloma.
Numbers along the x-axis represent individual animal identifiers.
(TIF)
S6 Fig. Linear scale of maximum CFU per granuloma and total lung bacterial burden. Ani-
mals were stratified for high or low risk of reactivation based on cut-offs determined by recur-
sive partitioning (high = 947.2 Total FDG Activity or the presence of extrapulmonary lesions).
(A) The maximum CFU per granuloma for an individual animal is greater in high-risk
(N = 10) compared to low risk (N = 12 animals. (B) High risk LTBI control animals had higher
total lung bacterial burden compared to low risk LTBI animals. The indicated p-values are
derived by Mann-Whitney. Each symbol represents an animal. Data are the same as in Fig 4A
and 4B but show a linear scale of bacterial burden.
(TIF)
PET CT Identifies Reactivation Risk from Latent Tuberculosis
PLOS Pathogens | DOI:10.1371/journal.ppat.1005739 July 5, 2016 14 / 17
S7 Fig. Range of bacterial burden per mediastinal LN (CFU/LN) for each high (N = 10) and
low (N = 12) risk latent control animal. Each symbol represents an individual MLN. Numbers
along the x-axis represent individual animal identifiers.
(TIFF)
S8 Fig. Gating strategy for surface and intracellular cytokine staining in lung granulomas.
After granulomas are harvested at necropsy and homogenized into single cell suspension, via-
ble cells were negatively selected based on the absence of viability marker (A). Lymphocytes
were selected based on SSC and FSC (i.e., size and granularity) (B). CD3+ were gated on the
lymphocyte population and defined as T cells (C) from which cytokine producing T cells (D-F)
were gated as in the example shown. Arrow indicates sequence of gating.
(TIF)
S9 Fig. Gating strategy for surface and intracellular cytokines staining of macaques
PBMCs. After PMBC was purified by percoll density gradient, cells were stimulated with Mtb
specific antigens or controls for 6 hours and stained for flow cytometry. From an arbitrary live
cell gate (A), Lymphocytes (B) were selected based on SSC and FSC (i.e., size and granularity).
CD4 or CD8 T cells (C) were gated on the lymphocyte population. From either CD4 or CD8 T
cells memory subsets (D) were selected based on CD45RA and CD27 markers as follows:
CD45RA+CD27+ as Naïve, CD45RA-CD27+ as Central memory, CD45RA-CD27- as Effector
memory and CD45RA+CD27- as Effector or terminally differentiated. Cytokine producing
CD4 or CD8 T cells or memory subsets were gated as shown (E-G) in the example shown here
for ESAT-6+CFP-10 stimulated cells with specific cytokine marker labeled antibody or isotype.
Arrows indicates sequence of gating.
(TIF)
S10 Fig. Intracellular cytokine staining of peripheral blood CD4 and CD8 T cells among
low (N = 8 macaques, blue) and high (N = 7 macaques, red) risk latently infected animals.
Mycobacterial antigen (ESAT6 and CFP10) specific production of single cytokine staining of
IFN-γ, IL-2, and TNF was determined from central memory (CD27+CD45Ra -), effector mem-
ory (CD27-CD45Ra-), and terminal effector (CD27-CD45Ra+) populations of CD4 and CD8
T cells. There were no differences in cytokine expression between high and low risk animals.
No differences were observed between high and low risk animals.
(TIF)
S11 Fig. Intracellular cytokine staining of peripheral blood CD4 and CD8 T cells among
low (N = 8 macaques, blue) and high (N = 7 macaques, red) risk latently infected animals.
Polyfunctional cytokine (IFN-γ, IL-2, and TNF) staining of mycobacterial antigen (ESAT6 and
CFP10) specific production T cells was examined among central memory (CD27+CD45Ra -),
effector memory (CD27-CD45Ra-), and terminal effector (CD27-CD45Ra+) populations of
CD4 and CD8 T cells. No differences were observed between high and low risk animals.
(TIF)
S12 Fig. Vaccine-induced protection from reactivation is associated with sterilized MLN.
In a previously published vaccine trial [16], macaques were vaccinated with either BCG, a com-
bination of BCG and H56 or were unvaccinated. Latent animals from each group were then
treated with anti-TNF antibody; 3 of 4 BCG-vaccinated animals reactivated, similar to latent
controls in that study while 0 of 4 BCG/H56 vaccinated animals reactivated. Here, the fre-
quency of MLN with growth ofM. tuberculosis was analyzed from those animals. The BCG/
H56 animals had a significantly lower proportion of Mtb-positive MLN than the control
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